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tomidine, regarding their efﬁciency in inducing deliberate hypotension and providing a better sur-
gical ﬁeld exposure during middle ear surgery. It also compared the inﬂuence of their use on
postoperative pain and recovery time.
Methods: Eighty-eight adult patients undergoing middle ear surgery were included. Patients were
randomly divided into two equal groups. Patients were assigned to receive either magnesium sul-
phate (M group) or dexmedetomidine (D group). Anaesthesia was induced by propofol 2 mg/kg
iv and fentanyl 1 lg/kg. Patients in the M group received an iv bolus of magnesium sulphate
50 mg/kg in a total of 100 ml saline over 10 min followed by infusion of 15 mg/kg/h until the
end of surgery. Similarly, patients in the D group received dexmedetomidine 1 lg/kg over 10 min
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228 O.H. Aboushanab et al.between 60 and 70 mmHg. The surgeon who was blinded of the selected hypotensive agent was
asked to assess the quality of the surgical ﬁeld. In the postanaesthesia care unit (PACU), postop-
erative pain was assessed and recovery time was recorded.
Results: Both study drugs succeeded to reach the target MAP. The quality of the surgical ﬁeld was
not different between the two groups. Postoperative pain was not different between the two group
and only eight patients in the M group and seven patients in the D group required analgesics.
Recovery time was signiﬁcantly longer for the patients in group D (p< 0.05).
Conclusion: We concluded that both magnesium sulphate and dexmedetomidine success-
fully induced deliberate hypotension in patients undergoing middle ear surgery but magnesium sul-
phate was associated with shorter recovery time and earlier discharge from the PACU.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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Deliberate hypotension is a technique which has been used to
decrease intraoperative bleeding and improve the quality of the
surgical ﬁeld for better visualization during middle ear surgery
and other head and neck operations [1–4].
Several pharmacologic agents have been used to produce
deliberate hypotension. Direct vasodilators as nitroprusside
and nitroglycerine, alpha-2 adrenergic agonists as clonidine
and dexmedetomidine, beta adrenergic antagonists as propran-
olol and esmolol, alpha and beta adrenergic antagonists as
labetalol, inhalational anaesthetics as isoﬂurane and sevoﬂu-
rane, l-receptors agonist as remifentanil, and N-methyl D-
aspartate antagonist as magnesium were all used to induce
hypotension during middle ear surgery [5–11].
Magnesium is the fourth most common salt in the human
body after phosphorus, calcium and potassium [12]. Magne-
sium sulphate was previously used to induce deliberate hypo-
tension [13,14]. It produces its hypotensive effect by limiting
the outﬂow of calcium from the sarcoplasmic reticulum and
produces a vasodilating effect by increasing the synthesis of
prostacyclin and inhibiting angiotensin converting enzyme
activity [15]. Hypotension induced by magnesium during sur-
gery is also explained by its powerful analgesic effect [16].
The analgesic action of magnesium is explained by its antago-
nistic effect at N-methyl D-aspartate receptors [17].
Dexmedetomidine is an a-2 adrenoreceptor agonist. It
decreases heart rate and arterial blood pressure by reducing
norepinephrine and epinephrine plasma levels [18]. Activation
of postsynaptic receptors in the central nervous system by
a2-agonists inhibits the sympathetic activity and decreases
heart rate and blood pressure and causes sedation.
No studies have been published to compare magnesium
sulphate and dexmedetomidine regarding their hypotensive
effects in patients undergoing middle ear surgery. The main
objective of this prospective randomized study was to compare
magnesium sulphate with dexmedetomidine as regards their
efﬁcacy in inducing deliberate hypotension and providing bet-
ter quality of the surgical ﬁeld during middle ear surgery. The
effect of both drugs on postoperative pain and recovery time
was also compared.
2. Methods
In this study, 88 adults ASA physical status I and II patients
undergoing middle ear surgery were included. A written in-
formed consent was obtained from all patients after approvalby the Local Ethics Committee. The enrollment period lasted
from January 2010 to March 2011 in Kasr El Eini University
Hospital in Cairo (Egypt). Patients with hepatic, renal, cardio-
vascular, neuromuscular or haematological disorders were ex-
cluded. Those with history of using sedatives, narcotics or
anticoagulants were also excluded. Patients were randomly as-
signed to receive either magnesium sulphate (M) or dexmede-
tomidine (D). Randomization was accomplished by using
computerized randomization tables. Anaesthesia was induced
by propofol 2 mg/kg iv and fentanyl 1 lg/kg. Patients in the
M group received an iv bolus of magnesium sulphate 50 mg/
kg in a total of 100 ml saline over 10 min followed by infusion
of 15 mg/kg/h until the end of operation. Similarly, patients in
the D group received dexmedetomidine 1 lg/kg over 10 min
followed by 0.4–0.8 lg/kg/h until the end of surgical procedure.
The study drugs were infused using an infusion pump (Module
DPS+IS3-Fresenius vial, Le Grand Chemin-38590, Brezins,
France). When the eyelid reﬂex was lost, rocuronium 0.6 mg/
kg was injected. A peripheral nerve stimulator (Plexygon nerve
stimulator Vygon I Talia S.r.L Via P. Dona, II, Padova, Italy,
Ref. 7501031 S/N0507PB202) was used at the wrist to monitor
neuromuscular block and the trachea was intubated when T1
was 0%. Additional doses of rocuronium were not adminis-
tered to allow intraoperative monitoring of facial nerve. When
T1 was 25%, muscle relaxation was reversed with atropine
0.02 mg/kg and neostigmine 0.04 mg/kg iv. Anaesthesia was
maintained with 1–2 MAC sevoﬂurane and lungs were venti-
lated with oxygen and medical air at a ratio of 1:1. Ringer’s
solution was infused continuously at a rate of 5 ml/kg/h. Mean
arterial pressure (MAP) and heart rate (HR) were recorded be-
fore induction of anaesthesia (baseline), 1 min after induction
of anaesthesia, 1 min before intubation, 1 min after intubation
then every 15 min intraoperatively, 1 min before extubation
and 5 min after extubation. (Drager Medical systems, Inc., Tel-
ford, PA 18969, USA). Blood samples for serum magnesium
were obtained before and after surgery. The target MAP during
operation was between 60 and 70 mmHg. If hypertension or
tachycardia more than 20% of the preoperative value occurred,
fentanyl 1 lg/kg was given iv. Sevoﬂurane concentration was
manipulated according to targeted MAP and its end-tidal con-
centration was recorded every 15 min while the patients were
intubated. If hypotension or bradycardia more than 20% of
the preoperative value occurred, 5 mg ephedrine for hypoten-
sion or 0.5 mg atropine for bradycardia was given iv. Before
skin closure all patients were given ondansetron 4 mg iv as an
antiemetic prophylaxis. The surgeon who was not aware of
the selected hypotensive agent was asked to assess the quality
Table 2 Pre- and postoperative serum magnesium levels.
Data are mean (SD).
Group M
(n= 44)
Group D
(n= 44)
Preoperative magnesium (mmol/l) 0.94 (0.14) 0.95 (0.16)
Postoperative magnesium (mmol/l) 1.3 (0.15) 0.91 (0.15)*
Group M: Magnesium sulphate, Group D: Dexmedetomedine.
* p= 0.008.
Magnesium and dexmedetomidine for deliberate hypotension. 229of the surgical ﬁeld according to the quality scale proposed by
Fromme and colleagues [19].
0 = no bleeding.
1 = slight bleeding – blood evacuation not necessary.
2 = slight bleeding – sometimes blood has to be evacuated.
3 = low bleeding – blood has to be often evacuated. Oper-
ative ﬁeld is visible for some seconds after evacuation.
4 = average bleeding – blood has to be often evacuated.
Operative ﬁeld is visible only right after evacuation.
5 = high bleeding – constant blood evacuation is needed.
Sometimes bleeding exceeds evacuation. Surgery is hardly
possible.
At the end of surgery, study drugs and sevoﬂurane were dis-
continued. Patients, after the end of surgery, were transferred to
the postanaesthesia care unit (PACU). In the PACU,MAP and
HR were recorded on admission and then 15 and 30 min later.
Pain was evaluated using visual analogue scale (VAS) starting
from 0 for no pain to 100 for worst pain. If VAS was >40,
ketorlac 30 mg iv was administered. Patients complaining of
postoperative nausea and vomiting were given metoclopramide
10 mg iv. Patients were discharged when fulﬁlling a score of 9
using a modiﬁed Aldrete scoring system [20]. Nurses of the
PACU were blinded to patients’ group allocation.
The primary outcome was the quality of surgical ﬁeld as-
sessed by the surgeon. A sample size of 44 in each group was
based on a pilot study we have conducted before. We assumed
that a 30% difference in the score of surgical ﬁeld quality
would be clinically signiﬁcant. A sample size was calculated
to be 40 at an alpha error of 0.05 and a beta error of 0.2. Be-
cause the primary outcome on which we calculated the sample
size was ordinal, we increased the sample size by 10%.
Data were statistically described in terms of mean (±SD),
frequencies (number of cases) and percentages when appropri-
ate. Data were tested ﬁrst for normal distribution by Klo-
mogorov–Smirnov test. Comparison of quantitative variables
between the study groups was done using Student t test for
independent samples if normally distributed. Mann–Whitney
U test was used for non-normally distributed quantitative
and ordinal data. For comparing categorical data, Chi square
(v2) test was performed. Exact test was used instead when the
expected frequency is less than 5. A probability value (p value)
less than 0.05 was considered statistically signiﬁcant. All statis-
tical calculations were done using computer programs Micro-
soft Excel 2007 (Microsoft Corporation, NY, USA) and
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows.Table 1 Patients characteristics. Data are mean (SD) or
number.
Group M (n= 44) Group D (n= 44)
Age (years) 32.4 (7.3) 34.1 (6.4)
Gender (male/female) 26/18 24/20
Weight (kg) 72.5 (9.7) 72.2 (9.1)
Height (cm) 164.2 (9.5) 163.0 (8.4)
ASA (I/II) 31/13 29/15
Group M: Magnesium sulphate, Group D: Dexmedetomedine.3. Results
One hundred and forty-one patients were found eligible for the
study. Forty-three patients met our exclusion criteria and 10
patients refused participation. Eighty-eight patients were ran-
domized to two groups: group M (n= 44) and group D
(n= 44). No patient was excluded from the study.
There were no signiﬁcant differences between the two
groups with regard to age, gender, weight, height and ASA
classiﬁcation as shown in Table 1. Postoperative magnesium
levels were signiﬁcantly higher in group M than in group D
as shown in Table 2.
There were no signiﬁcant differences between the two
groups neither in MAP as shown in Fig. 1 nor in HR as shown
in Fig. 2.
The two study groups were similar in terms of duration of
surgery and anaesthesia, type of surgery, bleeding quality score
and the need to atropine, ephedrine and fentanyl (Table 3)
Again the end-tidal concentrations of sevoﬂurane were sim-
ilar in the two study groups (Table 4)
Table 5 shows the difference between the two groups in the
PACU. Discharge from the PACU required a signiﬁcantly
longer time for the patients in the D group (p< 0.001).
4. Discussion
This study shows the ability of both magnesium sulphate and
dexmedetomidine to induce deliberate hypotension in patients
undergoing middle ear surgery. Mean arterial pressure was
successfully reduced to the target values in both groups. Both
drugs were equally successful to produce satisfactory surgical
ﬁeld. However the discharge time from PACU in dexmedetom-
idine group was almost double that in magnesium sulphate
group.
Magnesium sulphate is known to augment the action of
non-depolarizing neuromuscular blocking drugs and reduce
their consumption [21]. However, facial nerve monitoring is re-
quired during middle ear surgery and neuromuscular blocking
agents were reversed shortly after the beginning of the
operation.
Recovery in patients receiving dexmedetomidine was pro-
longed most probably due its sedative-sparing effects via cen-
tral actions in the locus coreuleus [22,23]. Other studies
observed that recovery time was prolonged in patients who re-
ceived dexmedetomidine for induced hypotension when com-
pared with control groups [6,24]. Another study observed
that there was a prolonged recovery time in patients received
dexmedetomidine when compared with those who received
remifentanil during gynaecologic laparoscopic surgery [25].
Figure. 1 Mean (SD) of mean arterial blood pressure (MAP, mmHg) between the study groups over the study period. M, Magnesium
sulphate group; D, Dexmedetomidine group; PACU, postanaesthesia care unit.
Figure. 2 Mean (SD) of heart rate (HR, beat/min) between the study groups over the study period. M, Magnesium sulphate group; D,
Dexmedetomidine group; PACU, postanaesthesia care unit.
Table 3 Intraoperative data. Data are mean (SD), median
(range) or number.
Group M (n= 44) Group D (n= 44)
Duration of surgery (min) 116 (18) 118 (17)
Type of surgery
Tympanoplasty 27 25
Mastoidectomy 17 19
Duration of anaesthesia 132 (18) 135 (19)
Surgical ﬁeld quality score 2.2 (1–4) 2.4 (1–4)
Atropine (no. of patients) 7 9
Ephedrine (no. of patients) 6 8
Fentanyl (no. of patients) 2 1
Group M: Magnesium sulphate, Group D: Dexmedetomedine.
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providing deliberate hypotension. Ryu and colleagues com-
pared magnesium sulphate and remifentanil and proved that
both drugs can induce adequate deliberate hypotension formiddle ear surgery but magnesium sulphate was associated
with better postoperative analgesia and less postoperative nau-
sea, vomiting and shivering [26]. Elsharnouby and colleagues
performed a placebo controlled study and concluded that mag-
nesium sulphate reduced MAP, HR and blood loss and was
associated with less anaesthetic requirements and emergence
time for patients underwent functional endoscopic sinus sur-
gery [13]. Yosri and colleagues designed a comparative study
between magnesium sulphate and nitroprusside and concluded
that magnesium sulphate could produce deliberate hypoten-
sion and provided good surgical conditions for resection of
choroidal melanoma with no need for adding potent hypoten-
sive agents [14]. Durmus and colleagues have proved in a pla-
cebo controlled study that dexmedetomidine decreased
bleeding and anaesthetic requirements in patients undergoing
tympanoplasty and septorhinoplasty [24]. Ayoglu and col-
leagues in a placebo controlled study concluded that dexmede-
tomidine reduced bleeding and improved visibility and
decreased analgesic requirements in septoplasty operations
[27]. Although magnesium sulphate and dexmedetomidine
Table 4 End-tidal concentrations of sevoﬂurane. Data are
mean (SD).
Group M (n= 44) Group D (n= 44)
15 min 2.6 (0.4) 2.5 (0.3)
30 min 2.3 (0.4) 2.3 (0.3)
45 min 2.4 (0.3) 2.4 (0.3)
60 min 2.3 (0.4) 2.2 (0.4)
75 min 2.2 (0.3) 2.2 (0.3)
90 min 2.3 (0.3) 2.3 (0.4)
105 min 2.4 (0.4) 2.2 (0.3)
120 min 2.3 (0.3) 2.3 (0.4)
135 min 1.4 (0.3) 1.3 (0.4)
150 min 0.7 (0.3) 0.8 (0.3)
Group M: Magnesium sulphate, Group D: Dexmedetomedine.
Table 5 PACU data. Data are mean (SD) or number.
Group M (n= 44) Group D (n= 44)
Time for discharge (min) 38.3 (5.2) 60.7 (6.8)*
VAS 0 34.8 (7.9) 34.4 (7.6)
VAS 15 34.6 (7.3) 35.8 (6.4)
VAS 30 27 (6.1) 28 (6.4)
Analgesic received 8 7
Antiemetic received 12 11
Group M: Magnesium sulphate, Group D: Dexmedetomedine.
VAS: visual analogue score of pain.
* p< 0.001.
Magnesium and dexmedetomidine for deliberate hypotension. 231were previously investigated as hypotensive agents, there were
no studies designed to compare between them as regards their
efﬁciency in controlling MAP and HR, analgesic effect and
emergence from general anaesthesia.
The target MAP between 60 and 70 mmHg was decided to
achieve hypotensive anaesthesia and bloodless ﬁeld without
subjecting the patients to peripheral tissue ischaemia. This tar-
get MAP was determined after revising previous studies in
which metabolic and hormonal responses were observed in pa-
tients subjected to induced hypotension. Yoshikawa and col-
leagues induced hypotensive anaesthesia using a similar
target MAP of 60–70 mmHg in patients undergoing mandibu-
lar osteotomy. They measured blood pyruvate, lactate and glu-
cose and observed insigniﬁcant increase in their levels. They
concluded that hypotension can be induced safely, if MAP is
maintained between 60 and 70 mmHg [28]. Newton and col-
leagues targeted a MAP of 55 mmHg in patients undergoing
middle ear surgery. They also observed insigniﬁcant increase
in blood lactate and pyruvate levels [29].
Our study was limited by the unavailability of two moni-
tors. We used a subjective scoring system to evaluate the qual-
ity of the surgical ﬁeld instead of a Laser Doppler ﬂowmetry
which was used by Degoute and colleagues to measure the
middle ear blood ﬂow [9]. We could not assess the depth of
anaesthesia as we lacked a bispectral index (BIS) monitor.
However the lack of any signiﬁcant differences in end-tidal
sevoﬂutane concentrations between the two groups suggests
that hypotensive properties of the two study drugs are similar
in the doses that we used.
Only 16% of patients in the magnesium group and 14% of
patients in the dexmedetomidine group required rescue analge-sics. These results can be explained by the analgesic properties
of both study drugs [17,18]
We concluded that both magnesium sulphate and dexmede-
tomidine successfully induced deliberate hypotension and good
surgical ﬁeld visibility but magnesium sulphate was associated
with shorter recovery time and earlier discharge from the
PACU.
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